Skip to main content
Cancer Explained
Donate

NewsResearch

Multi-Cancer Blood Tests, False Positives, and the Screening You Still Need

A multi-cancer blood test makes a prediction, not a diagnosis. It does not replace established screening and may lead to more testing.

By Cancer ExplainedPublished Updated

Original commentary from the Cancer Explained editorial team.

Two female clinicians review information together on a tablet
Two female clinicians review information together on a tablet — illustrative photograph, not of anyone named in this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

The test does not end with the blood draw

The appeal of a multi-cancer blood test is its simplicity at the front end. One appointment, one tube, one result.

What that image leaves out is everything that happens after a positive result. Somebody has to find the cancer the test predicted, and sometimes there is no cancer to find.

This page explains public sources. It is not medical advice and does not suggest a test or treatment.

One number worth remembering

NCI reports a figure from at least one study of these tests. Half the patients who had a positive result went through diagnostic testing and had no cancer detected at one year.

Sit with that for a moment. Half of the people who received alarming news, then underwent scans or procedures, ended the year without a cancer diagnosis.

That is not evidence the tests are useless. It is a description of what a positive result currently means: a reason to investigate, with roughly even odds in that study of finding nothing.

What the workup can involve

Some companies supply a list of likely organ sites to help a clinician start the search. NCI notes that a positive result can still lead to multiple follow-up tests and a prolonged process.

NCI names the costs of that process directly: anxiety, time, and financial expense. It also notes that each follow-up procedure carries its own risks and can cause physical harm.

There is a second-order effect too. NCI warns that these tests may increase medical mistrust if their characteristics and results are not explained well or understood.

A negative result is not a clean bill of health

NCI is equally clear in the other direction. Patients have been diagnosed with cancer despite a negative MCD result.

No test is currently accurate or broad enough for a negative result to mean a person does not have cancer. A person may have a cancer the test does not cover. Or the test may cover it and miss it anyway.

NCI lists the practical danger. A negative result may create false confidence that leads someone to skip standard screening, or to ignore a symptom that needs attention. A blood test result does not explain a lump, bleeding, persistent pain, or unexplained weight loss.

Overdiagnosis is on the list too

NCI includes overdiagnosis and overtreatment among the potential harms. Like other screening tests, MCD tests may not distinguish a slow-growing cancer that would never have caused trouble from one that would.

NCI's screening overview explains why this matters for interpreting survival figures. Lead-time bias, overdiagnosis, and healthy screenee bias can all make survival times look better without anyone actually living longer.

Every screening test carries some version of these tradeoffs. NCI's overview states them for screening generally: some tests cause serious problems, false-positive and false-negative results are both possible, and finding a cancer may not improve a person's health or help them live longer. Our page on the benefits and harms of screening covers how those are weighed against each other.

The screenings that stay on the list

NCI's answer here is a single word: yes. Standard-of-care cancer screenings are recommended regardless of whether a person has an MCD test.

NCI names four that expert groups consider effective: breast, cervical, colorectal, and lung cancer screening. It gives the reason. Those tests have been proven to find those specific cancers early, to reduce the chance of dying from them among people screened regularly, and to offer more potential benefit than harm.

No MCD test has met that standard. Our cancer screening overview covers which of these applies at which age, and our explainer on multi-cancer early detection blood tests covers the technology itself.

Before agreeing to the test

  • Which standard screenings should I continue no matter what this shows?
  • What tests would follow each possible result?
  • Who coordinates the workup, and how long might it take?
  • Who pays for follow-up if no cancer is found?
  • What happens if the result is uncertain rather than clearly positive or negative?

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Put the story in context

Prevention, possible warning signs, screening, and diagnosis

This story relates to Multi-cancer tests and screening. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.

  • Prevention and risk reduction

    Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.

    NCI prevention information

  • Symptoms and possible early signs

    Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.

    NCI signs and symptoms

  • Screening and early detection

    Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.

    NCI cancer screening information

  • How cancer is diagnosed

    Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.

    NCI diagnosis information

A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.

Go deeper with NCI